Retail investors show strength in Tattva Chintan Pharma’s IPO, 33.1 times full stake, 144 times subscription | Retail investors show strength in Tattva Chintan Pharma’s IPO, 33.1 times full stake, 180 times total subscription

Advertisement

  • Hindi News
  • Business
  • Retail Investors Show Strength In Tattva Chintan Pharma’s IPO, 33.1 Times Full Stake, 144 Times Subscription

Mumbai7 hours ago

  • copy link
  • The company had reserved 35% for retail. Still it got great response
  • Retail’s share in Nazara Tech was 75 times which is the highest in the recent issue

Tattva Chintan Pharma’s IPO has joined the list of 100 times filling issue. Also, retail investors have shown great interest in it. The retail share is more than 35 times full. It got a total response of 180 times. The company had reserved 35% for retail. Still it has got great response.

pharma sector company

Tattva Chintan is a pharma sector company. Its IPO opened on Friday. It closed on Tuesday. Among the recent IPOs that have got more than 100 times subscription, the biggest hit has been MTAR. It got a response of 200.79 times. In this, the share of retail was filled more than 28 times. Mrs. Bacteria’s issue was filled 198 times. In this, the share of retail was filled more than 29 times.

The issue of view was filled 175 times

Similarly, the IPO of Najara Technology was full 175 times and retail investors showed maximum interest in it. Their share was filled more than 75 times. In EasyTrip, a total response of 159 times was received from investors and the share of retail was filled 70.4 times. This is the second hit IPO in the case of retail.

Shyam Metallics has also been a hit IPO

Shyam Metallics has also been a hit IPO. In this, the retail share was filled only 11.6 times, but the entire IPO was filled 121 times. The share of retail in Lakshmi Organic was 20.1 times and the total was 106 times. GR Retail’s share in infra was filled at 12.5 times and the total share was filled 102 times. It more than doubled the amount of investors in the listing on Monday. Its listing was done above Rs 1700.

Advertisement

Entered the market for 500 crores

Tattva Chintan Pharma Chemical has entered the market to raise Rs 500 crore. The issue opened on 16 July. Its price range was fixed from Rs 1073 to Rs 1082. The company has earmarked 50% of the issue for QIBs while 15% for non-institutionalised. The company will use the proceeds of this IPO for expansion of its Dahej unit, for the development of its research and development center in Vadodara and for the needs of the company. A minimum lot of 13 shares was kept for investing in IPO.

manufactures specialty chemicals

Tattva Chintan Specialty Chemicals is a Vadodara based company. The company exports most of its products to 25 countries. These include the US, China, Germany, Japan, South Africa and the UK. The company had a profit of Rs 37.78 crore in the March quarter of the financial year 2020 and income was Rs 263.23 crore.

Statistics show that in the biggest IPO that has come since March, the IPO of Nazara Technology was filled 4.01 times on the first day. After this, the element in the subscription on the first day is Chintan Pharma. Its IPO was full 5 times on the first day. The retail share was 7 times full on the first day.

There is more news…

.

Source link

Advertisement

Leave a Reply